Acorda Therapeutics (ACOR) Tops Q2 EPS by 22c
Tweet
Share
E-mail
Get Alerts ACOR Hot Sheet
Price: $0.66 --0%
Financial Fact:
Total other expense (net): -4.54M
Today's EPS Names:
OCCI, IPX, ALZN, More
Financial Fact:
Total other expense (net): -4.54M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q2 EPS of ($1.87), $0.22 better than the analyst estimate of ($2.09). Revenue for the quarter came in at $31.78 million versus the consensus estimate of $29.94 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- Costco Wholesale (COST) PT Raised to $1,040 at DA Davidson Following Q4 Earnings
- Moody’s raises BJ’s Wholesale outlook to positive on debt reduction
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
